Investigational mosquito-transmitted diseases vaccine targets mosquito saliva: NIH
by Press Release from Outbreak News Today on (#2DFQP)
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial to test an investigational vaccine intended to provide broad protection against a range of mosquito-transmitted diseases, such as Zika, malaria, West Nile fever and dengue fever, and to hinder the ability of ["]
The post Investigational mosquito-transmitted diseases vaccine targets mosquito saliva: NIH appeared first on Outbreak News Today.